3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Neoplasms
10
Melanoma
9
Breast Neoplasms
8
Lung Neoplasms
7
Multiple Myeloma
6
Leukemia, Myeloid, Acute
6
Prostatic Neoplasms
5
Ovarian Neoplasms
5
Neoplasm Metastasis
5
Brain Neoplasms
5
Pancreatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Endometrial Neoplasms
4
Colorectal Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Myelodysplastic Syndromes
3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
3
Carcinoma, Transitional Cell
3
Carcinoma, Renal Cell
3
Urinary Bladder Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Solid Tumors
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Recurrence
2
Rectal Neoplasms
2
Interventions
tusamitamab ravtansine
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Non-small Cell Lung Cancer Metastatic
×
30 days
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts